Samantha Pearce, SVP, Head of Europe & Internat at Jazz Pharmaceuticals plc (JAZZ), sold 531 shares at $155.00 ($82K) on 2022-08-04, disclosed to the SEC on 2022-08-08.
Open-market sale of $82k JAZZ by SVP, Head of Europe & Internat. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| JAZZ | SELL | 2023-01-05 | $169K | — | Filing → |
| JAZZ | SELL | 2022-12-15 | $165K | — | Filing → |
| JAZZ | SELL | 2022-11-14 | $165K | — | Filing → |